LivaNova PLC

NASDAQ:LIVN

44.33

-2.34 (-5.01%)

5:02:00 PM EDT: $45.13 +0.80 (+1.81%)

Market Cap (Intraday)	2.42B
Current PE	N/A
Forward PE	12.15
2yr Forward PE	11.25

See more stats

Estimates Current Quarter

Revenue	$332.21 Million
Adjusted EPS	$0.87

See more estimates

10-Day MA	$45.88
50-Day MA	$44.08
200-Day MA	$46.04

See more pivots

LivaNova PLC Stock, NASDAQ:LIVN

20 Eastbourne Terrace, 20 Eastbourne Terrace, London, Greater London W2 6LG

United Kingdom

Phone: +44.203.325.0660

Number of Employees: 2900

http://www.livanova.com

Description

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.